Movicol and Diplopia - a phase IV clinical study of FDA data
Summary:
Diplopia is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are female, 60+ old, also take Zolpidem, and have Atrial fibrillation/flutter.
The phase IV clinical study analyzes which people have Diplopia when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
What is Diplopia?
Diplopia (double vision) is found to be associated with 1,428 drugs and 1,895 conditions by eHealthMe. Check the latest studies of Diplopia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14,199 people reported to have side effects when taking Movicol.
Among them, 34 people (0.24%) have Diplopia.

Among these 34 people:
What is the gender of people who have Diplopia when taking Movicol? *
- female: 94.12 %
- male: 5.88 %
What is the age of people who have Diplopia when taking Movicol? *
- 0-1: 0.0 %
- 2-9: 7.14 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 3.57 %
- 40-49: 25.0 %
- 50-59: 0.0 %
- 60+: 64.29 %
What are other drugs people take besides Movicol? *
- Zolpidem: 18 people, 52.94%
- Xarelto: 17 people, 50.00%
- Cordarone: 17 people, 50.00%
- Cymbalta: 17 people, 50.00%
- Aldactone: 16 people, 47.06%
- Rocephin: 6 people, 17.65%
- Gilenya: 6 people, 17.65%
- Atenolol: 5 people, 14.71%
- Flagyl: 5 people, 14.71%
- Furosemide: 5 people, 14.71%
What are other side effects people have besides Diplopia? *
- Dyspnea (difficult or laboured breathing): 22 people, 64.71%
- Depression: 21 people, 61.76%
- Optic Neuropathy (optic nerve damage): 18 people, 52.94%
- Optic Neuritis (optic nerve inflammation): 17 people, 50.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 17 people, 50.00%
- Papilloedema (optic disc swelling): 17 people, 50.00%
- Eye Haemorrhage (bleeding in the eye): 17 people, 50.00%
- Parkinson's Disease: 17 people, 50.00%
- Cerebellar Syndrome (impaired blood circulation to cerebellum due to lesion in artery): 17 people, 50.00%
- Pleural Effusion (water on the lungs): 17 people, 50.00%
What are the existing conditions these people have? *
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 14 people, 41.18%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 17.65%
- Oedema (fluid collection in tissue): 6 people, 17.65%
- Cardiac Failure: 5 people, 14.71%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 11.76%
- Gait Disturbance: 4 people, 11.76%
- Muscle Spasms (muscle contraction): 3 people, 8.82%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.82%
- Simple Partial Seizures (seizures which affect only a small region of the brain): 2 people, 5.88%
- Partial Seizures With Secondary Generalisation (partial seizure may spread within the brain, a process known as secondary generalization): 2 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Movicol and have Diplopia?
- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Movicol:
- Movicol (14,249 reports)
Diplopia treatments and more:
- Diplopia (32,466 reports)
How severe was Diplopia and when was it recovered:
Expand to all the drugs that have ingredients of polyethylene glycol 3350:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Diplopia:
- Diplopia (1,428 drugs)
Browse all the conditions that are associated with Diplopia:
- Diplopia (1,895 conditions)
Related publications that referenced our studies
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Prednisone cause Cystitis Klebsiella? - a second ago
- Could Hctz cause Spinal Pain? - 10 seconds ago
- Could Neupogen cause Dyskinesia Aggravated? - 16 seconds ago
- Could Zomig cause Appetite - Decreased? - 23 seconds ago
- Could Zomig cause Appetite Decreased? - 23 seconds ago
- Could Hydrochlorothiazide cause Cystitis Interstitial? - 24 seconds ago
- Could Neulasta cause Nasopharyngitis? - 33 seconds ago
- Could Haloperidol cause Thirst - Excessive? - 33 seconds ago
- Could Sotalol Hydrochloride cause Dyspnea Exacerbated? - 34 seconds ago
- Could Haloperidol cause Hypoaesthesia? - 36 seconds ago